Medicinal cannabis has become increasingly available in Australia under the Authorised Prescriber and SAS pathways.
Rather than focusing on products, this article will discuss the broader clinical landscape: how cannabinoid science intersects with pain, sleep, mood regulation, and inflammation; what patients should consider when exploring treatment; and how an integrative approach supports safety, monitoring, and informed decision-making.
This piece will not promote or advertise any specific product, instead, it will provide context, education, and a balanced clinical perspective.
